Evidence map›Paper›PMID 35656025›Full record

ArticleOxidative medicine and cellular longevity2022

HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation.

Shangting Han, Fangyou Lin, Yucheng Qi, Cong Liu, Linxiang Zhou, Yuqi Xia, Kang Chen, Ji Xing, Zilin Liu, Weimin Yu and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 91 citations in OpenAlex.

  1. Targeting Cancer Hallmarks withInternational journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Ferroptosis: a potential target for non-surgical treatment of laryngeal cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Shangting HanDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID https://orcid.org/0000-0002-1429-4009
Fangyou LinDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID https://orcid.org/0000-0001-7369-7855
Yucheng QiDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID https://orcid.org/0000-0001-5780-2424
Cong LiuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Linxiang ZhouDepartment of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Yuqi XiaDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Kang ChenDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Ji XingDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zilin LiuDepartment of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Weimin YuDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Yunlong ZhangDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Xiangjun ZhouDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Ting RaoDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID https://orcid.org/0000-0001-8915-4855
Fan ChengDepartment of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China.ORCID https://orcid.org/0000-0002-3471-6221
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis, a novel form of regulated cell death characterized by disrupted iron metabolism and the accumulation of lipid peroxides, has exhibited enormous potential in the therapy of cancer particularly clear cell renal cell carcinoma (ccRCC). Luteolin (Lut), a natural flavonoid widely existing in various fruits and vegetables, has been proven to exert potent anticancer activity

Indexed as

Carcinoma, Renal CellFerroptosisKidney NeoplasmsHumansIronLipid PeroxidationLuteolinMolecular Docking SimulationReactive Oxygen SpeciesIronLuteolinReactive Oxygen Species

Identifiers

PMID35656025
PMCPMC9153929
OpenAlexW4224861896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.